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Endocytosisat renal tubular cells may serve as a reservoir for HIV-1, however the mechanism
underlying this ﬁnding has not been studied. Here we show that primary human renal proximal tubular
epithelial cells (HRPTECs) have the potential to harbor HIV-1 through the DEC-205 receptor. The interaction
of HIV-1 with DEC-205 results in the rapid internalization of the virus for lysosomal degradation, without
establishing a productive infection. However, a small fraction of incoming virus escapes degradation and can
be rescued by T cells. Since pH-modulating agents and an inhibitor of endosomal transport increased HIV-1
accumulation and trans-infection to T cells, it appears that HRPTECs endocytic compartments may be the site
of viral persistence and transmission to target cells. The ability of T cells to rescue the virus from HRPTECs
further supports the hypothesis that these cells have the potential to serve as a reservoir for HIV-1.
© 2008 Elsevier Inc. All rights reserved.Introduction
HIV-1 enters susceptible cells by fusion of its envelope with the
plasma membrane after binding to the CD4 molecule (Dalgleish et al.,
1984) and interaction with the chemokine co-receptors, CCR5 or
CXCR4 (Stantchev and Broder, 2001). Nevertheless, HIV-1 entry into
CD4-negative human cells has beenwidely reported, including neural
cells (Haraouse et al., 1989; Li et al., 1990), astrocytes (Tornatore et al.,
1994), trophoblasts (Douglas et al., 1989), oral keratinocytes (Vachar-
aska et al., 2008), and several organ speciﬁc epithelial cells–colonic
epithelial cells (Adachi et al., 1987; Fantini et al., 1991), cervical
epithelial cells (Phillips and Bourinbaiar, 1989; Bourinbaiar and
Phillips, 1991; Pearce-Pratt et al., 1994), and intestinal epithelial cells
(Meng et al., 2003). In the majority of instances, the HIV-1 entry into
CD4 negative cells occurred through the endocytic pathways
(Vidricaire et al., 2004; Vidricaire and Tremblay, 2007; Li et al.,
2007; Meng et al., 2003). These pathways lead to different outcomes
including recycling, degradation, antigen presentation, transcytosis of
internalized molecules, and sometime trapping of the incoming
virions within endocytic compartments. Therefore, HIV-1 entry
through endocytic pathway (as is the case for internalized molecules)
may be associated with different outcomes. For example, theases and Hypertension, 100
16 465 3011.
l rights reserved.endocytic-mediated capture of HIV-1 results in the productive
infection in astrocytes (Li et al., 2007) and trophoblasts (Vidricaire et
al., 2003); whereas, in many other CD4-negative cells, the virus
penetration results in the abortive interaction (Vacharaska et al.,
2008; Dezzutti et al., 2001). However, the non-replicative HIV-1 status
in these cells does not prevent viral transmission to the permissive
cells (Meng et al., 2003; Vacharaska et al., 2008; Dezzutti et al., 2001).
Thus, it appears that the endocytic pathway not only contributes to
HIV-1 transmission and dissemination but may also provide a
potential to change the course of HIV-1 infection in vivo. Moreover,
these ﬁndings support the hypothesis that CD4-negative cells can
serve as an important reservoir for HIV-1.
Human renal proximal tubular epithelial cells (HRPTECs) do not
express the classical HIV-1 receptors. Although the presence of CD4,
CCR5 and CXCR4 in tubular cells were reported in one study (Conaldi
et al., 1998) we and others failed to conﬁrm those ﬁndings (Eitner et
al., 2000; Hatsukari et al., 2007). Recently, we have demonstrated that
DEC-205 serves as a receptor for HIV-1 in HK-2 cells (Hatsukari et al.,
2007). DEC-205 belongs to the family of C-type lectin-like receptors,
which are abundantly expressed on dendritic cells (DCs) as well as on
many epithelial cells (Jiang et al., 1995; Mahnke et al., 2000; Steinman,
1996; Witmer-Pack et al., 1995). Like other C-type lectin receptors
(DC-SIGN and macrophage mannose receptor, MMR), DEC-205 is a
professional endocytic receptor and plays an important role in antigen
capture and presentation of peptides to T cells (Jiang et al., 1995,
Mahnke et al., 2000). In the present study, we have demonstrated that
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act as an HIV-1 receptor. Interaction of HRPTECs with primary HIV-1
results in the rapid internalization of the virus in low pH compart-
ments for degradation (without establishing a productive infection).
Furthermore, our data show that the productive infection in HRPTECs
is not required for trans-infection of HIV-1 to T cells through the
physical contact between these cells. Vesicular pH modulating agents,
such as chloroquine (CLQ), ammonium chloride (NH4CL), and
baﬁlomycin A (BFLA-1), or an inhibitor of endosomal transport
(nocodazole) not only increased HIV-1 accumulation in HRPTECs but
also promoted the viral transmission to T cells. These ﬁndings suggest
that HRPTECs' endocytic compartments may be the site of viral
transmission to the target cells. Moreover, it appears that the viral
entry through the endocytic pathway provides an opportunity for
HRPTECs to serve as a reservoir for HIV-1.
Since HRPTECs serve as antigen-presenting cells (APC), we propose
that they have an important role in HIV-1 dissemination in vivo. These
cells are well suited to participate in immune collaboration. They are
not only exposed to innumerable immunogenic peptides from blood
and glomerular ﬁltrate, but also express surface molecules which
facilitate their engagement toT cells (Rubin-Kelley and Jevnikar, 1991).
In addition, phlogogenic cytokine-induced upregulation of tubular cell
MHC class I and MHC class II molecules is likely to activate antigen-
speciﬁc CD4 and CD8 T cells through the formation of the
immunological synapse between HRPTECs and T cells (Meyers, 1999;
Rubin-Kelley and Jevnikar, 1991; van Kooten et al., 1999). TheseFig. 1. Internalization of HIV-1 in HRPTECs. Before inoculation, HIV-1 was treated with 200 U/
with viral DNA. (A) HRPTECs were exposed to different primary HIV-1 strains: R5 HIV-192US71
with the virus for 24 h, thenwashed once with PBS, treated with 0.05% trypsin at 37 °C for 10
culture. After 24 h cells were trypsinized again, washed, lysed, and analyzed for HIV-speciﬁc
adequacy of viral washing, HIV-1 non-permissive 293T cells were used as a control. (C) HRPTE
indicated times of pulsingwithHIV-1, HRPTECswere trypsinized,washed and analyzed for LTR
of two independent experiments. (D) Dilutions of 8E5/LAI cells that contained one HIV-1 geno
of the α-tubulin gene was used to control for the amount of DNA and mock infection servedﬁndings are consistent with the widely recognized concept of the
“Trojan horse” model of HIV-1 trans-infection in which exocytosis of
virion-laden vesicles into the synapse promoted efﬁcient infection in
CD4 T cells (Cavrois et al., 2008).
Results
HIV-1 entry into HRPTECs
To determine entry of HIV-1 into the primary human renal
proximal tubular epithelial cells (HRPTECs), the cells were exposed
to primary strains of HIV-1 with different co-receptor usage: R5
HIV-192US714 and HIV-192US660, X4 HIV-1M279 and HIV-192HT599, and
R5X4, HIV-192US723. Immediately after infection, cells were washed
one time with PBS, followed by trypsinization for 10 min at 37 °C (to
eliminate non-internalized virus) and then washed again with PBS
(four times). Fig. 1A shows HRPTECs were positive for HIV-1-speciﬁc
strong-stop DNA (LTR RU5), of all analyzed viral strains. To verify
adequacy of viral washing, HIV-1-non-permissive (293T) cells, were
used as a control. Contrary to the HRPTECs, 293T cells were negative
for LTR RU5 (Fig. 1B). These results indicate that HRPTECs are
permissive to HIV-1 entry regardless of the viral co-receptor usage.
Since we did not detect the late reverse transcripts (pol, gag), it
appears that HIV-1 does not establish productive infection (data not
shown) and the proviral DNA corresponding to the strong-stop DNA
detected in HRPTECs was associated with virions. To determine theml of RNase-free DNase for 1 h at room temperature in order to eliminate contamination
4 and HIV-192US660, X4 HIV-1M279 and HIV-192HT599, R5X4 HIV-192US723. Cells were pulsed
min to eliminate non-internalized virus, washed again four times with PBS and plated in
LTR RU5 by PCR. One representative experiment out of two is shown. (B) To verify the
Cs were incubated with HIV-192US660 at 4 °C, after 1 h, cells were transferred to 37 °C. At
RU5byPCR. Relative LTRRU5 cpmare expressed as themeans±standard deviation (S.D.)
me per cell were used as PCR standards (HIV-1 copies). In all experiments, ampliﬁcation
as a negative control.
Fig. 2. Detection of virus-speciﬁc p24 and p-17 in HIV-1-pulsed HRPTECs. HRPTECs were exposed to either primary HIV-192HT599 or media (control) for 4 h. Afterwards, cells were
trypsinized, washed ﬁve times and left to adhere on poly-L-lysine-treated glass coverslips for 2 h at 37 °C. Cells were then ﬁxed, permeabilized and co-stained with anti-p24 and anti-
p17 antibodies. HRPTECs loaded with HIV-1 were analyzed by confocal microscopy. Representative microphotographs of HRPTECs are shown with the corresponding HIV-1 and
nuclear markers: green—p24; red—p17 and blue—DAPI (nucleus). The images were collected using a 40× numerical aperture with Zeiss Axiomot confocal microscope, using LSM 510
scan head and software. Control cells did not show any labeling for p24 and p17 (data not shown).
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performed. To allow the viral attachment only (without any initiation
of endocytosis), cells were pre-incubated with HIV-192US660 for 1 h at
4 °C. Subsequently, cells were transferred to 37 °C (to allowFig. 3. Anti-DEC-205 antibody inhibits HIV-1 entry into HRPTECs. (A) Cells were analyzed
within the C-type lectin-like domains on DEC-205 or with the Isotype. One representative e
were prepared and probed with anti-DEC-205 antibody. (C) HRPTECs were pre-incubated wit
30min, followed by pulsing with HIV-192US660 (pre-treated with 200 U/ml of RNase-free DNa
LTR RU5 by PCR. The percent of inhibition represents (Means±S.D, n=3) the ratio of the re
Control. (D) Dose–response of anti-DEC-205 antibody. Ampliﬁcation of the α-tubulin gene w
presence of HIV-1-speciﬁc-strong-stop DNA. Mock pulsing served as a negative control.internalization of the bound virus in synchronous way) and incubated
for different time periods. The results show rapid internalization of the
virus. The HIV-1-speciﬁc strong-stop DNAwas detected in HRPTECs as
early as 30min after incubation (Fig.1C), followed by intracellular HIV-by ﬂow cytometry after staining with anti-DEC-205 antibody that recognizes epitopes
xperiment out of four is shown. (B) Protein was extracted from HRPTECs. Western blots
h media (Control), anti-DEC-205 antibody (30 μg/ml), or isotype antibody (30 μg/ml) for
se) for 2 h. Subsequently, cells were trypsinized, washed and analyzed for HIV-1-speciﬁc
lative LTR RU5 cpm between samples treated with anti-DEC-205 antibody/Isotype and
as used to control for amount of DNA. One representative experiment is shown for the
Fig. 4. Detection of intracellular localization of viral-like particles by electron
microscopy. HRPTECs were washed and ﬁxed after different times of incubation with
HIV-1. Fixed cells were scraped, stained and embedded. Thin-sections were cut and
evaluated under electron microscopy. Viral like particles are shown by white arrows in
various vesicular compartments at early time points (A–C) and at the later time period
into a late endosome (D) and into a multivesicular body (E–F). Arrowheads show fusion
of vesicles to form an early endosome (B). Mag. ×70,000.
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detection at 0 min, it conﬁrms the absence of non-speciﬁc viral
attachment to the cell membrane. To conﬁrm tubular cell HIV-1
internalization, we carried out immunoﬂuorescence studies using
HIV-1-speciﬁc antibodies. In these studies, at 4 h of incubation, we
observed the presence of viral capsid (p24gag) and matrix (p17)
antigens in about 20% of HRPTECs (Fig. 2).
Entry of HIV-1 into HRPTECs is mediated through DEC-205
Recently we have demonstrated that C-type lectin DEC-205 acts as
an HIV-1 receptor in the human kidney cell (HK-2) line. Therefore, we
wanted to determine the possible role of DEC-205 in HIV-1 entry into
primary human renal proximal tubular cells (HRPTECs). To determine
the expression of DEC-205 receptors in HRPTECs, cells were labeled
with anti-DEC-205 antibody followed by FACS analysis. As shown in
Fig. 3A, 25% of cells showed the expression of DEC-205. Western
blotting studies conﬁrmed tubular cell expression of DEC-205 (Fig.
3B). In order to verify whether DEC-205 mediates HIV-1 entry in
HRPTECs, cells were pre-treated with anti-DEC-205 or isotype anti-
body prior to the incubation with the virus. Anti-DEC-205-antibody
markedly decreased viral entry in a dose-dependent manner, with the
maximum of inhibition at concentration of 30 μg/ml (Figs. 3C–D).
Intracellular localization of HIV-1 particles in HRPTECs by electron
microscopy studies
In EM studies (after 30 min incubation of HRPTECs with HIV-1),
HIV-1-like particles (80–110 nm size with a central core) were
detected in the small intracellular vesicles localized in a close
proximity to the plasma membrane and in early endosomes (Figs.
4A–C). Extended incubation with the virus resulted in the accumula-
tion of viral-like particles in compartments containing intralumenal
vesicles, which were designated late endosomes/MVBs (D–F).
Approximately, 12–15% cells (13.8±1.5% cells) showed the presence
of HIV-1 like particles in HIV-1 pulsed tubular cells. We found only
occasional particles that vaguely resemble HIV-1 in control cells.
HIV-1 degradation in HRPTECs depends on low pH compartments
To gain insight into vesicular trafﬁc, we evaluated the effect of
vesicular pH modulating agents and an endosomal inhibitor on the
intracellular accumulation of HIV-1 in HRPTECs. Cells treated with an
inhibitor of vacuolar proton ATPase, baﬁlomycin A1 (BFLA-1), showed
an increase in the amount of HIV-1-speciﬁc strong-stop DNA (Fig. 5A).
Similarly, other agents known to block vesicle acidiﬁcation as well as
endosomal and lysosomal degradation systems (chloroquine, CLQ and
ammonium chloride, NH4Cl), increased the amount of HIV-1-speciﬁc
strong-stop DNA in HRPTECs. In addition, nocodazole, an agent that
prevents early-to-late endosome transition, increased accumulation
of HIV-1 in HRPTECs (Fig. 5A). These ﬁndings suggest that after entry
into HRPTECs, the virus is targeted to low pH compartments (late
endosomes/lysosomes) for its degradation.
To further conﬁrm the role of DEC-205 in targeting HIV-1 particles
to the low pH compartments, we used 293T cells, which do not
express any of the known classical HIV-1 receptors or DEC-205. We
treated DEC-205-transfected 293T cells with pH modulating agents
(BFLA-1, CLQ, and NH4Cl) and nocodazole before and during incuba-
tion with HIV-1 and analyzed strong-stop DNA synthesis by PCR.
Similar to HRPTECs, DEC-205-transfected-293T cells showed increase
of HIV-1-speciﬁc strong-stop DNA after treatment with BFLA-1, CLQ,
NH4Cl and nocodazole (data not shown).
Since C-type lectin receptors are associated with the clathrin-
mediated endocytosis (Howard and Isacke, 2002), we studied the
effect of chlorpromazine (CHLP), a known inhibitor of clathrin-
dependent endocytosis, on HIV-1 entry in HRPTECs. Since CHLP didnot modulate HIV-1 internalization in HRPTECs, it appears that
clathrin-coated vesicles did not participate in DEC-205-mediated
HIV-1 endocytosis (Fig. 5A). To clarify the difference between the role
of clathrin in HV-1 uptake through C-lectin DC-SIGN vs. DEC-205, we
used 293T (these cells do not express either DC-SIGN or DEC-205)
cells; therefore, to evaluate the HIV-1 entry into these cells, 293T cells
were transfected with either DEC-205, DC-SIGN, or control plasmids.
Only the expression of DEC-205 and DC-SIGN rendered 293T cells
permissive to HIV-1 (Figs. 5B, C, data on control plasmid is not shown).
Similar to HRPTECs, CHLP had no effect on HIV-1 strong-stop DNA
concentration in DEC-205-transfected-293T cells; in contrast, DC-
SIGN-transfected-293T cells showed signiﬁcant inhibition of the HIV-
1 entry in response to CHLP. The drug concentrations used in this
study, were tested with the MTT assay (data not shown).
Fig. 5. Effect of endosomal pathway inhibitors on HIV-1 trafﬁc in HRPTECs. (A) HRPTECs were pre-incubated either in media (Control), CLQ (250 μM), BFLA-1 (100 nM), NH4CL
(20 mM), CHLP (5 μM) or Nocodazole (15 nM) for 1 h followed by pulsing with HIV-192US660 (pre-treated with 200 U/ml of RNase-free DNase). After 4 h of treatment cells were
trypsinized, washed and analyzed for HIV-1-speciﬁc LTR RU5 by PCR. Relative LTR RU5 cpm represent the means±S.D. of three independent experiments. One representative
experiment out of three is shown for the presence of HIV-1-speciﬁc-strong-stop DNA. (B) Expression of DEC-205 and DC-SIGN in transfected 293T cell. Cells were transfected with
plasmids that expressed either DEC-205, DC-SIGN, or respective controls (control data is not shown). After 3 days of transfection, cells were stained with either FITC-labeled anti-
DEC-205, anti-DC-SIGN or respective isotype antibodies. (C) Effect of CHLP on HIV-1 entry in DEC-205- and DC-SIGN-transfected 293T cells. Cells were pre-incubated in media
containing either buffer (Control) or CHLP (5 μM) for 1 h followed by pulsing with HIV-192US660 for 1 h. Subsequently, cells were trypsinized, washed and analyzed for HIV-1-speciﬁc
LTR RU5 by PCR. One representative experiment out of two is shown for the presence of HIV-1-speciﬁc-strong-stop DNA. In A and C, ampliﬁcation of the α-tubulin gene was used to
control for the amount of DNA and mock pulsing served as a negative control.
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A time course study was carried out to evaluate the kinetic of
HIV-1 degradation in HRPTECs. We have analyzed the strong-stop
DNA in HIV-pulsed HRPTECs at different time periods after removal
of the virus (Fig. 6A). Most of the viral degradation was observed at
24 h. HRPTECs showed the presence of the virus at a later time
point, 72 h. These results suggest that HIV-1 can persist in HRPTECs
for a longer period of time. To determine if the persisting virus can
be rescued by target cells, HIV-1 pulsed HRPTECs were co-cultivated
with activated T cells. As shown in Fig. 6B, HIV-1 could be rescued
from HRPTECs after 24 and 72 h of removal of the virus. Similar
results were obtained in DEC-205-transfected 293T cells (data not
shown).
Transmission of the virus from HRPTECs to T cells requires
cell-to-cell contact
Next, we wished to determine whether HIV-1 transmission from
HRPTECs to T cells requires release of HIV-1 particles into the
extracellular milieu or cell-to-cell contact. To address this question,
we set up a co-cultivation system which separated infected
HRPTECs from T cells during co-culture by membrane (trans-well)
with a cut off of 0.4 μm, to avoid cell-to-cell adhesion. In parallel,
HIV-pulsed HRPTECs were co-cultured directly with T cells. As
shown in Fig. 7A, HIV-pulsed HRPTECs did not transmit HIV-1 to T
cells in trans-well, while direct co-culture yielded positive results.In addition, cell-free supernatants harvested from HIV-1-pulsed
HRPTECs were tested for their capacity to induce the productive
infection in T cells. Fig. 7B shows that the supernatants collected
from HRPTECs 24 h and 48 h after HIV-1 treatment were not able
to infect T cells. Similar results were obtained with the super-
natants harvested 12 h and 72 h after HIV-1 exposure (data not
shown).
Since CD40/CD40L interaction has been considered critical for
the activation of HRPTECs by T cells (Kuroiwa et al., 2000), we
stimulated HIV-1 pulsed HRPTECs with the CD40L in combination
with the proinﬂammatory cytokine IFN-γ, which promotes the
upregulation of MHC class II and co-stimulatory molecules on
tubular cells (Chen et al., 2006; de Haij et al., 2005; Schoop et al.,
2004; Waeckler-Men et al., 2007; Wahl and Wuthrich, 2004). This
strategy was adopted to evaluate whether tubular cell activation can
induce the exocytosis of the virus. No p24 was detected in the cell-
culture medium of HIV-1 pulsed HRPTECs after IFN-γ/CD40L
stimulation and no infection was observed in T cells co-cultured
with these cells, grown in trans-well (data not shown). These results
indicate that cell-to-cell contact is required for HIV-1 transmission
from HRPTECs to T cells.
Inhibition of HIV-1 degradation in HRPTECs enhances trans-infection to
T cells.
As shown in Fig. 8, treatment of HRPTECs with BFLA-1, CLQ, and
NH4CL increased the trans-infection of HIV-1 to T cells; these ﬁndings
Fig. 6. Degradation and escape of HIV-1 in HRPTECs. HRPTECs were pulsed with HIV-
192US660. Before inoculation viral stock was treated with 200 U/ml of RNase-free
DNase. After 6 h of incubation with HIV-1, HRPTECs were trypsinized, washed and
analyzed for HIV-1-speciﬁc LTR RU5 (Control) or cultured and analyzed for HIV-1 LTR
RU5 after additional 12 h, 24 h, 48 h and 72 h. (A) Ampliﬁcation of the α-tubulin
gene was used to control for the amount of DNA. Relative LTR RU5 cpm represent
means±S.D. of two independent experiments. One representative experiment out of
two is shown for the presence of HIV-1-speciﬁc-strong-stop DNA. Mock served as a
negative control. (B) HRPTECs were incubated 6 h with HIV-192US660, trypsinized,
washed and plated in culture for 24 h or 72 h. Afterwards, cells were washed
extensively and activated T cells were added in ratio 1:2. Viral replication was
analyzed by RT assay in lymphocyte supernatants that were collected at different
time points after co-cultivation. The data represent the means±S.D. of two
independent experiments.
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cells. Nocodazole (a blocker of the trafﬁcking pathway between early
and late endosomes) also increased the rescue of the virus by T cells;
nevertheless, infection in T cells was 50% lower when compared with
the effect of pH modulating agents. However, these results suggest
that early endosomes also contribute to HIV-1 trans-infection. Since
the treatment with chlorpromazine did not inhibit viral transmission
to T cells, it appears that clathrin-independent uptake of virus is
involved in trans-infection (data not shown).
Degradation and escape of HIV-1 virus in HRPTECs is not
proteasome-dependent
As shown in Fig. 9A, treatment with MG132 did not modulate the
levels of HIV-1-speciﬁc strong-stop DNA in HRPTECs. Furthermore,
proteasome blocking had no effect on the trans-infection of T cells
incubated with HIV-pulsed HRPTECs (Fig. 9B).
Proposed hypothetical model for HIV-1 trans-infection from HRPTECs to
T cells
Fig. 10 shows a proposed model for HIV-1 trans-infection from
tubular cells to T cells.Discussion
Interaction of HRPTECs with HIV-1 results in the rapid internaliza-
tion of the virus in low pH compartments, without establishing a
productive infection. Since T cells are able to rescue the infectious
virus from the tubular cells it appears that the productive infection in
HRPTECs is not a pre-requisite for trans-infection of HIV-1 to target
cells. BFLA-1-, CLQ- and NH4Cl-treated tubular cells showed an
increase in viral accumulation in endosomal vesicles, indicating that
endosomal compartments contribute to HIV-1 intracellular trafﬁcking
and degradation. Because nocodazole, an inhibitor of early-to-late
endosome transition, also increased the HIV-1 strong-stop DNA, it
indicates that HIV-1 particles are directed from early to late
endosomes. BFLA-1, CLQ, and NH4CL also increased viral transmission
from HRPTECs to T cells. These ﬁndings suggest that a functional
correlation exists between the accumulation of HIV-1 in compart-
ments (whose pH have been altered) and the viral transmission to the
target cells. Electron microscopic studies also conﬁrmed that
intracellular viral trafﬁcking occurs from membrane to endosomes,
which contributes to the accumulation of viral particles in compart-
ments containingmultiple intralumenal vesicles (multivesicular body,
MVB). Interestingly, infectivity of cell-free virus has been reported to
be more stable at mildly acid pH vs. at neutral pH (Garcia et al., 2005).
These ﬁndings provide an explanation for the continuation of viral
residency in acid pH compartments of HRPTECs (without the
establishment of the productive infection).
In the present study, we observed that DEC-205 supports HIV-1
binding and entry into HRPTECs. Since T-20, a known HIV-1 fusion
inhibitor, did not show any effect on HIV-1 entry in HRPTECs
(unpublished data), it conﬁrms that the viral entry into tubular cells
did not depend on classical fusion-mediated penetration; however, it
appears that the other mechanisms are involved in the viral entry into
HRPTECs. In the present study, we demonstrated the important role of
DEC-205 and the endocytic pathway in the viral uptake by HRPTECs.
Since anti-DEC-205 antibody did not inhibit viral entry completely, we
cannot exclude the role of other involved pathways for the HIV-1
internalization in HRPTECs.
Although DEC-205 has been reported to participate in clathrin-
mediated endocytosis (Jiang et al., 1995; Mahnke et al., 2000) we did
not ﬁnd any evidence for clathrin-dependent process during the
HRPTEC uptake of HIV-1 and in DEC-205-transfected-293T cells. On
the other hand, DC-SIGN-transfected 293T cells showed the participa-
tion of a clathrin-mediated pathway for HIV-1 entry. DEC-205
receptor is perhaps the least understood member of the MMR family
of C-type lectins and many functional differences have been noticed
between DEC-205 and its homologous receptors (Stahl and Ezekowitz,
1998; Feinberg et al., 2000; Bonifaz et al., 2004; Mahnke et al., 2000).
Although the cytosolic tail of DEC-205 contains the coated pit
sequence (Mahnke et al., 2000) the mutation of tyrosine-containing
motif (characteristic for other coated pit-mediated internalization
receptors) did not abolish its function (Chen et al., 1990; Amigorena et
al., 1992; Jackman et al., 1998). Moreover, the different functional
region of acidic amino acids in the distal part of DEC-205 tail, has been
demonstrated to be critical for its lysosomal targeting (Mahnke et al.,
2000); however, this study was performed with a chimeric receptor
containing only the external domain of CD16 and cytosolic tail of DEC-
205 (without performing any ligand-speciﬁc study). Since the
internalization pathway through other C-lectin receptors (such as
DC-SIGN) depends on the nature of captured ligands (Ludwig et al.,
2004), we propose that DEC-205 mediated endocytic pathway may
also be determined by the speciﬁcity of DEC-205-captured ligand.
Nevertheless, our conclusionwas entirely based on experiments using
chlorpromazine, which is known to modulate cell function besides its
action on clathrin coated vesicles (Sieczkarski and Whittaker, 2002).
However, for better understanding of the interaction between HIV-1
and DEC-205, more speciﬁc assays will be needed.
Fig. 7. T cells require cell-to-cell contact to capture HIV-1 from HRPTECs. (A) HRPTECs were pulsed with R5 HIV-192US660 or with X4 HIV-192HT599 for 6 h, then trypsinized, washed
extensively and co-cultivated with pre-activated T cells in the ratio 1:2 either directly or in trans-wells (with 0.4 μm pore size). In positive controls, human macrophages (MO) were
infected with R5 HIV-192US660 and co-cultivated with T cells in the presence of a trans-well for 3 days; subsequently, T cells were transferred to the newmedia. In all the experiments,
respective supernatants (incubation media) were collected after 3, 7, 10, and 14 days and analyzed for p24 antigen. (B) HRPTECs were pulsed with HIV-192HT599 for 6 h, then
trypsinized, washed and plated in culture. After 24 h and 48 h the collected supernatants were centrifuged and tested on activated Tcells in ratio 1:2. Viral replicationwas analyzed in
lymphocyte supernatants after 3, 7, 10 and 14 days by RT assay. One representative experiment out of two is shown. The data represent the means±S.D. of triplicate samples.
111J. Mikulak et al. / Virology 385 (2009) 105–114DCs can capture HIV-1 in an infectious form and transfer the virus
to CD4 T cells by an “infectious synapse” requiring cell-to cell contact
(McDonald et al., 2003). Also, the phenomenon of exocytosis of
vesicle-associated HIV-1 particles capable of infecting the target cells
has also been shown in DCs (Wiley and Gummuluuru, 2006). In
addition, lymphocytes can extract surface molecules through the
“immunological synapse” from the antigen-presenting cells (APCs) by
a process called “trogocytosis” (Huang et al., 1999). This phenomenon
involves the transfer of plasmamembrane fragments from APCs to theFig. 8. Endosomal pathway inhibitors enhance the rescue of virus from HIV-1-pulsed
HRPTECs. HRPTECs were pre-incubated with either media (Control) or with CLQ
(250 μM), BFLA-A (100 nM), NH4CL (20 mM), or Nocodazole (15 nM) for 1 h, followed by
pulsing with HIV-192US660. After 4 h of incubation with the virus, cells were trypsinized,
washed and co-cultivated with activated T cells in the ratio 1:2. Viral replication was
analyzed in lymphocyte supernatants after 3, 7 and 10 days by RT assay. Mock pulsing
served as a negative control. The data show the means±S.D. of two independent
experiments.lymphocytes. In the present study, we demonstrated that infectious
HIV-1 particles captured by HRPTECs are efﬁciently transferred to
target cells only upon cell-to-cell contact. Despite stimulationwith the
strong HRPTECs activators including activated T cells supernatants
(Kuroiwa et al., 2000), IFN-γ, CD40L (Chen et al., 2006; de Haij et al.,
2005; Schoop et al., 2004; Waeckler-Men et al., 2007; Wahl and
Wuthrich, 2004), and HRPTECs were neither able to release the
infectious viral particles nor they were able to establish viral
replication in T cells. Kuroiwa et al. have reported that the activation
of renal tubular cells may vary depending on the type of stimuli by
inﬁltrating T cells (soluble factors) or by cell-to-cell contact (contact
dependent factors). Our ﬁndings depicting the role of cell-to-cell
adhesion (between HRPTECs and T cells) in the viral trans-infection
are consistent with these investigators.
Studies from several laboratories have indicated that trans-
infection of HIV-1 through the DC-SIGN receptor involves internaliza-
tion of virus into endocytic compartments (Kwon et al., 2002). For
example, Garcia et al. characterized dendritic endocytic vesicles which
are involved in the internalization and the transport of virus to the
immunological synapse — the intracellular compartments containing
tetraspanins such as CD81 and CD9 at pH of 6.2 (Garcia et al., 2005).
On the other hand, the cellular machinery involved in MVB formation
has been required to complete HIV-1 assembly in macrophages (Finzi
et al., 2006; Pelchen-Matthews et al., 2003; Raposo et al., 2002). These
observations have lead to the proposal that HIV-1 might subvert
similar trafﬁcking pathways for viral budding and for trans-infection
to T cells (Amara and Littman, 2003; Pelchen-Matthews et al., 2003).
Therefore, it will be worthwhile to investigate the involved tubular
cell compartments in viral escape in future studies.
Fig. 9. Proteasome inhibitor has no effect on HIV-1 degradation in HRPTECs and escape
of virus. HRPTECs were pre-incubatedwith eithermedia (Control) or MG132 (20 μM) for
1 h followed by pulsing with HIV-192US660. Before pulsing, viral stock was treated with
200 U/ml of RNase-free DNase. After 4 h of incubation, cells were trypsinized, washed
and analyzed for LTR RU5 by PCR (A), or co-cultured with pre-activated T cells (B). Viral
replication in B was analyzed in lymphocyte supernatants collected 3, 7 and 10 days
after co-cultivation by RT assay. The data show the means±S.D. of two independent
experiments. One representative experiment out of two is shown in A. Mock pulsing
served as a negative control.
Fig. 10. Proposed hypothetical model for HIV-1 trans-infection from tubular cells to T cells.
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commonly used as an anti-malarial drug in HIV-endemic regions of
world. Chloroquine has been reported to modulate HIV-1 activity by
multiple ways including modiﬁcation of glycosylation of gp120
(Rayne et al., 2004; Naarding et al., 2007), enhancement of HIV-1
infection in vitro (Vijaykumar et al. 2008), and acceleration of
viral replication in malaria-endemic areas (Kamya et al., 2001; Seth
et al., 1999). In the present study, chloroquine not only enhanced
accumulation of viral particles in HRPTECs but also enhanced trans-
infection to T cells. On the basis of these ﬁndings as well as reports
by other investigators we suggest that administration of chlor-
oquine carries a potential to change the course of HIV infection.
Human immunodeﬁciency virus-associated nephropathy
(HIVAN) is the third most common cause of end-stage renal disease
in adult males of Afro-American background (Bourgoignie and
Pardo, 1991; Pardo et al., 1984; Rao et al., 1984). For a long time it
was not clear whether the pathogenesis of HIVAN was due to HIV
infection of the renal cells or due to an indirect effect of the altered
immune system (Cohen et al., 1989; Kimmel et al., 1993). Studies
that were designed to address this issue showed that that the
expression of the HIV-1 transgene in renal cells was necessary and
sufﬁcient for the development of HIVAN (Bruggeman et al., 1997).
These observations imply a direct role of HIV-1 infection in the
development of HIVAN. Moreover, viral transcripts as well as the
presence of viral proteins have been found in both glomerular and
tubular epithelial cells in HIVAN biopsy specimens (Cohen et al.,
1989; Bruggeman et al., 2000; Marras et al., 2002; Tanji et al., 2006).
In an isolated case report, it has been reported that there was a
persistence of HIV-1 mRNA in tubular cells despite the disappear-
ance of viral load from the blood following highly active anti-
retroviral therapy (HAART) (Winston et al., 2001). The phenomenon
of capture of HIV-1 particles by renal tubular cells may in part
provide an explanation for the presence of signiﬁcant amounts of
HIV-1 products detected in tubular cells of HIVAN patients. Since
recently it has been documented that in CD4-negative cells, the
capture of HIV-1 in the endocytic compartments may result in
establishment of productive infection (Li et al., 2007; Vijaykumar etal., 2008), we would like to hypothesize that the non-replicating
viral status in HRPTECs could be altered under in vivo conditions. It
will be important to verify this hypothesis in future studies.
Materials and methods
Reagents
Chloroquine (CLQ), Baﬁlomycin A1 (BFLA-1), Nocodazole,
Ammonium chloride (NH4Cl), Chlorpromazine (CHLP) and MG132
were purchased from Sigma-Aldrich (St. Louis, MO, USA), and were
used in the following concentrations: CLQ, 250 μM; BFLA-1,
100 nM; NH4CL, 20 mM; Nocodazole, 15 nM; CHLP 5 μM and
MG132 20 μM. Recombinant human IFN-γ (200 U/ml) was
purchased from BD Pharmingen (San Jose, CA, USA). Recombinant
human soluble CD40L was used in the concentration of 1 μg/ml in
the presence of an enhancer (1 μg/ml) (Prod. No. ALX-804-034,
Alexis Biochemicals, San Diego, CA, USA). T-20 (Roche, Indianapolis,
IN) was obtained from NIH AIDS Research and Reference Reagent
Program, cat. No. 9845.
Cells and viruses
Human primary renal primary proximal tubular epithelial cells
(HRPTECs) were obtained from ScienCell (San Diego, CA, USA) and
were characterized by an immunoﬂuorescent method with antibodies
to cytokeratin-18, -19 and vimentin. 293T cells were obtained from
ATCC (Manassas, VA, USA). Primary macrophages and lymphocytes
were isolated from peripheral blood mononuclear cells of HIV-1
negative donors as described previously (Hatsukari et al., 2007).
Several strains of HIV-1 were used including R5 (HIV-192US714 and
HIV-192US660), X4 (HIV-1M279, HIV-192HT599), and R5X4 (HIV-192US723).
Viral inoculums were adjusted according to reverse transcriptase (RT)
activity to 20×104 cpm/ml. In co-cultivation studies, lymphocytes
activated with phytohemagglutinin (PHA, 5 μg/ml, Sigma) were added
to HRPTECs in a ratio of 2:1 in a medium supplemented with 20 U/ml
of IL-2 (Roche). Viral replication in supernatants was analyzed by RT
assay or p24 Ag detection by ELISA. 293T cells were transfected with
pEGFP plasmid expressing human DEC-205 (a kind gift from Dr. Ralph
Steinman, The Rockefeller University, New York, NY) or green
ﬂuorescence protein (GFP; Clontech, Mountain View, CA) and with
pcDNA3 plasmid expressing human DC-SIGN (NIH AIDS Research and
Reference Reagent Program, cat. no. 5444) or with pcDNA3.1
(Invitrogen, Carlsbad, CA) using FuGENE transfection kit (Roche). In
blocking studies, cells were pre-treated with anti-DEC-205 antibody
(clone MG38), or an isotype control (both from Serotec, Raleigh, NC)
for 30 min before HIV-1 treatment.
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Before pulsing, viral stocks were treated (1 h at room temperature)
with 200 U/ml of RNase-free DNase (Roche). Before preparation of cell
lysates, control and HIV-pulsed cells were washed oncewith PBS, then
treated with 0.05% trypsin at 37 °C for 10 min to eliminate non-
internalized virus, and subsequently washed four times with PBS. Cell
lysates were subjected to PCR analysis using HIV-1 speciﬁc primers
amplifying LTR RU5 and pol transcripts as described previously
(Hatsukari et al., 2007). Ampliﬁed DNA was analyzed by Southern
blot hybridization using 32P-labeled probes. Ampliﬁcation of the α-
tubulin gene was used to control the amount of DNA in each sample.
Serial dilutions of 8E5/LAI cells, containing one HIV-1 genome per cell,
were included in each ampliﬁcation reaction to standardize the results.
HIV-1 p24 Ag detection
HIV-1 p24 Ag concentrations in the culture supernatants were
determined by ELISA (Moore et al., 1990). In brief, cell-free culture
supernatants were lysed with Empigen BB followed by p24 capture by
an immobilized anti-p24 Ag polyclonal antibody (D7320) (Aalto Bio
Reagents, Dublin, Ireland). Bound p24 Ag was then detected using an
alkaline phosphatase-conjugated anti-p24 Ag monoclonal antibody
(BC 1071-AP, Aalto Bio Reagents) and the AMPAK ELISA ampliﬁcation
system (DAKO A/S, Glostrup, Denmark).
RT assay
RT activity in the supernatants of HIV-pulsed cells was assayed as
described previously (Willey et al., 1988). In brief, 10 μl of cell-free
culture supernatants were added to 50 μl of an RT reaction mixture
which contained a template primer of poly (A) (5 μg/ml) (Boehringer,
Ingelheim, Germany) and oligo (dT) (1.57 μg/ml) (Amersham) in
50 mM Tris–HCL, pH 7.8, 20 mM KCL, 5 mM MgCl2, 1 mM
dithiothreitol, and 40 μCi/ml 3H-labeled deoxythymidine 5-tripho-
sphate (dTTP) (Amersham) in a 96-well ﬂat-bottomed microtiter
plate, and incubated at 37 °C. 5 μl of the RT reaction was then spotted
onto DE81 paper (Whatman, Maidstone, England), dried, washed, and
subsequently counted on a microplate scintillation counter (Packard
Instrument Co., Meriden, CT).
Confocal microscopy
The following antibodies were used: sheep anti-p24 polyclonal
antibody (D7320; Aalto Bio Reagents, Dublin, Ireland), rabbit anti-p17
MA (NIH AIDS Research and Reference Reagent Program, cat. no.
4811), anti-sheep IgG-NL493 (R&D System, Minneapolis, MN, USA),
and anti-rabbit IgG Alexa Flour 546 (Molecular Probes, Eugene, OR,
USA). HRPTECs were exposed either to primary HIV-192HT599 or media
(control) for 4 h. Afterwards, cells were trypsinized, washed ﬁve times
and left to adhere on poly-L-lysine-treated glass coverslips for 2 h at
37 °C. Then the cells were ﬁxed with paraformaldehyde, permeabi-
lizedwith 0.2% Triton X-100, and blocked by 5% bovine serum albumin
(BSA-PBS). Cells were stained with primary antibodies in 5% BSA-PBS,
then washed with 0.1% Triton X-100, and stained with secondary
antibodies in 5% BSA-PBS. After extensive washes, cells were mounted
and examined by confocal microscopy. As a negative control, non HIV-
1-treated cells were incubated with both primary and secondary
antibodies.
Electron microscopy (EM)
HRPTECs were pulsed with HIV-1 at different time points 5 min,
15 min, 30 min, 24 h, and 72 h. At the end of pulsing, cells were
washed and ﬁxed within 2% glutaraldehyde, buffered with 0.05 M Na
cacodylate (pH 7.3), and prepared for EM.Western blot
HRPTECswere lysed in Ripa buffer (50mMTris–HCL pH 8,1% Triton
X-100, 100 mM NaCl, 1 mMMgCl2). The protein fraction was analyzed
on 8% SDS-PAGE, followed by transfer to nitrocellulose membrane
(Bio-Rad, Hercules, CA), and immunoblotted with primary rabbit anti-
DEC-205 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Blotswere developedwithHRP-conjugated anti-rabbit IgG (Santa Cruz
Biotechnology), followed by ECL (Perkin Elmer, Boston, MA).
Flow cytometric analysis
HRPTECs were washed with PBS and blocked with PBS containing
20% human serum. Afterward, cells were stained with anti-DEC-205
(Clone MG38), anti-DC-SIGN (clone DCN46) monoclonal antibodies
directly labeled with FITC (eBiosciences, San Diego, CA, USA), or with
corresponding mouse isotype antibody IgG2b-FITC (eBiosciences).
After washing, cells were ﬁxed with 2% buffered formalin. Staining
was analyzed on FACS Calibur (Becton Dickinson, San Jose, CA) using
Cell Quest software.
MTT assay
Cell viability in the presence of used drug concentrations was
determined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazo-
lium bromide (MTT) (Sigma) assay as described previously (Mos-
mann, 1983).
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